Skip to main content
IDXX logo

IDXX · Idexx Laboratories Inc /De · Analyst Estimates

Track IDXX — free
$524.36 +2.17 (+0.42%)
Market Cap
$40.91B
Shares
78.78M
Volume · Oct 1 32.24K Avg daily vol (3M) 572.41K

Analyst Estimates

Compare analyst forecasts for Idexx Laboratories Inc /De across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-26 19:31 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
14.46
14.82721
15.177
—
14.83498
14.66329
14.83498
14.66965
— — — —
EPS
analysts
Publication date not stated
— — —
12
— — — —
0
0
11
2
Revenue
USD
Publication date not stated
4710300000
4722557070
4738117060
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
12
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
16.06984
16.73722
17.132
—
16.7397
16.51678
16.7397
16.52308
— — — —
EPS
analysts
Publication date not stated
— — —
12
— — — —
2
1
11
2
Revenue
USD
Publication date not stated
5096396730
5140881750
5195017930
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
12
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
3.37
3.70284
3.906
—
3.7074
3.7824
3.7074
3.78333
— — — —
EPS
analysts
Publication date not stated
— — —
11
— — — —
7
1
3
2
Revenue
USD
Publication date not stated
1182500000
1190732430
1203000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
10
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
3.09
3.35821
3.546
—
3.36501
3.44868
3.36501
3.4493
— — — —
EPS
analysts
Publication date not stated
— — —
10
— — — —
8
8
1
1
Revenue
USD
Publication date not stated
1166000000
1173804110
1184021310
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
9
— — — — — — — —
Key facts CIK 874716 CUSIP 45168D104 13F (30d) 21 filings 17 filers Visit website Investor relations